Effect of co-existing auto-immunity disorders on subclinical atherosclerosis To avoid the potential confounding effect of co-existing autoimmune diseases about subclinical atherosclerosis [6], all the analyses were repeated after excluding subjects with Systemic Lupus Erythematosus (SLE) or additional autoimmune … Continue reading Effect of co-existing auto-immunity disorders on subclinical atherosclerosis To avoid the potential confounding effect of co-existing autoimmune diseases about subclinical atherosclerosis [6], all the analyses were repeated after excluding subjects with Systemic Lupus Erythematosus (SLE) or additional autoimmune diseases and, as compared with controls, a higher CCA-IMT, Bulb-IMT and prevalence of carotid plaques were confirmed in APP service providers and in APS subjects (Fig